Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6420 |
BMS-707035
N-[(4-氟苯基)甲基1,6-二氢-5-羟基-1-甲基-6-氧代-2-(四氢-1,1-二氧-2H-1,2-噻嗪-2-基)-4-嘧啶甲酰胺 |
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
BMS707035是一种 HIV-1 整合酶抑制剂,IC50为15 nM。 | |||
T15483 |
LEDGIN6
HIV-1 integrase inhibitor 2 |
Others | Others |
HIV-1 integrase inhibitor 2 is used for the treatment of human immunodeficiency virus (HIV) infection. | |||
T72162 |
HIV-1 integrase inhibitor 10
|
||
HIV-1integrase inhibitor 10 是一种 HIV-1变构整合酶抑制剂 (ALLINI),具有口服活性。HIV-1integrase inhibitor 10 可抑制 NLRepRluc 病毒在 MT-2 细胞中的生长,其 EC50值为 3-5 nM。HIV-1integrase inhibitor 10 可用于人类免疫缺陷病毒-1 (HIV-1) 的研究。 | |||
T36794 |
Dolutegravir O-β-D-Glucuronide
|
||
Dolutegravir O-β-D-glucuronide is a metabolite of the HIV integrase inhibitor dolutegravir .1It is formed from dolutegravir primarily by the UDP-glucuronosyltransferase (UGT) isoform UGT1A1in vivobut is also metabolized by UGT1A9 in human liver and kidney microsomes and UGT1A3 in human intestinal microsomes.2,1 1.Liu, S.N., Lu, J.B., Watson, C.J.W., et al.Mechanistic assessment of extrahepatic contributions to glucuronidation of integrase strand transfer inhibitorsDrug Metab. Dispos.47(5)535-544... |